Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • Rockwell Medical's Prepaid Assets rose 2937.66% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 2937.66%. This contributed to the annual value of $1.4 million for FY2024, which is 2784.57% up from last year.
  • Per Rockwell Medical's latest filing, its Prepaid Assets stood at $1.5 million for Q3 2025, which was up 2937.66% from $943000.0 recorded in Q2 2025.
  • Rockwell Medical's 5-year Prepaid Assets high stood at $3.2 million for Q2 2022, and its period low was $910000.0 during Q1 2024.
  • For the 5-year period, Rockwell Medical's Prepaid Assets averaged around $1.7 million, with its median value being $1.5 million (2023).
  • Its Prepaid Assets has fluctuated over the past 5 years, first crashed by 5913.95% in 2021, then skyrocketed by 12675.16% in 2022.
  • Quarter analysis of 5 years shows Rockwell Medical's Prepaid Assets stood at $2.9 million in 2021, then crashed by 39.01% to $1.7 million in 2022, then plummeted by 39.08% to $1.1 million in 2023, then grew by 27.85% to $1.4 million in 2024, then rose by 11.48% to $1.5 million in 2025.
  • Its Prepaid Assets stands at $1.5 million for Q3 2025, versus $943000.0 for Q2 2025 and $988000.0 for Q1 2025.